Literature DB >> 29605069

Acetaminophen (APAP or N-Acetyl-p-Aminophenol) and Acute Liver Failure.

Chalermrat Bunchorntavakul1, K Rajender Reddy2.   

Abstract

Acetaminophen (APAP) is the leading cause of acute liver failure (ALF), although the worldwide frequency is variable. APAP hepatotoxicity develops either following intentional overdose or unintentional ingestion (therapeutic misadventure) in the background of several factors, such as concomitant use of alcohol and certain medications that facilitate the formation of reactive and toxic metabolites. Spontaneous survival is more common in APAP-induced ALF compared with non-APAP etiologies. N-acetylcysteine is recommended for all patients with APAP-induced ALF and it reduces mortality. Liver transplantation should be offered early to those who are unlikely to survive based on described prognostic criteria.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acetaminophen; Acute liver failure; Drug-induced liver injury; Hepatotoxicity; Liver transplantation; N-acetylcysteine; Overdose

Mesh:

Substances:

Year:  2018        PMID: 29605069     DOI: 10.1016/j.cld.2018.01.007

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  17 in total

1.  Mechanistic identification of biofluid metabolite changes as markers of acetaminophen-induced liver toxicity in rats.

Authors:  Venkat R Pannala; Kalyan C Vinnakota; Kristopher D Rawls; Shanea K Estes; Tracy P O'Brien; Richard L Printz; Jason A Papin; Jaques Reifman; Masakazu Shiota; Jamey D Young; Anders Wallqvist
Journal:  Toxicol Appl Pharmacol       Date:  2019-04-08       Impact factor: 4.219

2.  Aldehyde dehydrogenase-2 activation decreases acetaminophen hepatotoxicity by prevention of mitochondrial depolarization.

Authors:  Hereward J Wimborne; Jiangting Hu; Kenji Takemoto; Nga T Nguyen; Hartmut Jaeschke; John J Lemasters; Zhi Zhong
Journal:  Toxicol Appl Pharmacol       Date:  2020-03-30       Impact factor: 4.219

Review 3.  Biomarkers of drug-induced liver injury: progress and utility in research, medicine, and regulation.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  Expert Rev Mol Diagn       Date:  2018-08-13       Impact factor: 5.225

4.  Gut-Resident Lactobacilli Activate Hepatic Nrf2 and Protect Against Oxidative Liver Injury.

Authors:  Bejan J Saeedi; Ken H Liu; Joshua A Owens; Sarah Hunter-Chang; Mary C Camacho; Richard U Eboka; Bindu Chandrasekharan; Nusaiba F Baker; Trevor M Darby; Brian S Robinson; Rheinallt M Jones; Dean P Jones; Andrew S Neish
Journal:  Cell Metab       Date:  2020-03-25       Impact factor: 27.287

5.  Continuous Venovenous Hemofiltration as a Rescue Therapy for Severe Acetaminophen Toxicity in a Toddler.

Authors:  Puspraj Awasthi; Ankush Jindal; Yogish Sharma; Vijai Williams; Namita Ravikumar; Karthi Nallasamy; Suresh Kumar Angurana
Journal:  J Pediatr Intensive Care       Date:  2020-05-22

6.  Differential regulation of hepatic physiology and injury by the TAM receptors Axl and Mer.

Authors:  Anna Zagórska; Paqui G Través; Lidia Jiménez-García; Jenna D Strickland; Joanne Oh; Francisco J Tapia; Rafael Mayoral; Patrick Burrola; Bryan L Copple; Greg Lemke
Journal:  Life Sci Alliance       Date:  2020-06-22

7.  Astragaloside IV Attenuates Acetaminophen-Induced Liver Injuries in Mice by Activating the Nrf2 Signaling Pathway.

Authors:  Lei Li; Wenxiang Huang; Shoukai Wang; Kecheng Sun; Wenxue Zhang; Yanmei Ding; Le Zhang; Bayaer Tumen; Lili Ji; Chang Liu
Journal:  Molecules       Date:  2018-08-14       Impact factor: 4.411

Review 8.  Transplantation of mesenchymal stem cells and their derivatives effectively promotes liver regeneration to attenuate acetaminophen-induced liver injury.

Authors:  Chenxia Hu; Lingfei Zhao; Zhongwen Wu; Lanjuan Li
Journal:  Stem Cell Res Ther       Date:  2020-02-27       Impact factor: 6.832

Review 9.  Diagnostic Biomarkers in Liver Injury by Drugs, Herbs, and Alcohol: Tricky Dilemma after EMA Correctly and Officially Retracted Letter of Support.

Authors:  Rolf Teschke; Axel Eickhoff; Amy C Brown; Manuela G Neuman; Johannes Schulze
Journal:  Int J Mol Sci       Date:  2019-12-27       Impact factor: 5.923

10.  Microenvironment Activatable Nanoprodrug Based on Gripper-like Cyclic Phenylboronic Acid to Precisely and Effectively Alleviate Drug-induced Hepatitis.

Authors:  Qixiong Zhang; Shanshan Li; Lulu Cai; Yuxuan Zhu; Xingmei Duan; Peidu Jiang; Lei Zhong; Kun Guo; Rongsheng Tong
Journal:  Theranostics       Date:  2021-07-13       Impact factor: 11.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.